Imatinib mesilate inhibits melanogenesis in vitro.
Cario-André
M
M
Ardilouze
L
L
Pain
C
C
Gauthier
Y
Y
Mahon
F-X
FX
Taieb
A
A
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001549:Benzamides; D002478:Cells, Cultured; D004817:Epidermis / Q000187:drug effects; D006801:Humans; D000068877:Imatinib Mesylate; D008543:Melanins / Q000096:biosynthesis*; D008544:Melanocytes / Q000187:drug effects* / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D046509:Tissue Culture Techniques; D014820:Vitiligo / Q000378:metabolism*
D000970:Antineoplastic Agents; D001549:Benzamides; D008543:Melanins; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate